Celgene Corporation
Manufacturer / marketing-authorisation holder
Celgene Corporation — 26 products across 1 markets, 12 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Celgene Corporation — 26 productos en 1 mercados, 12 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Celgene Corporation —— 共 26 个产品，覆盖 1 个市场、12 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
26 products · 1 markets · 12 brand names
26 productos · 1 mercados · 12 marcas
26 个产品 · 1 个市场 · 12 个品牌名
Products by country
US
Source: api.fda.gov
| Brand | Active ingredient(s) | Form |
|---|---|---|
| ISTODAX | Ingredient not recorded (name-level) | kit |
| Idhifa | Enasidenib | tablet |
| Idhifa | Enasidenib | tablet |
| Inrebic | Fedratinib | capsule |
| ONUREG | 阿扎胞苷 | tablet |
| ONUREG | 阿扎胞苷 | tablet |
| Pomalyst | 泊马度胺 | capsule |
| Pomalyst | 泊马度胺 | capsule |
| Pomalyst | 泊马度胺 | capsule |
| Pomalyst | 泊马度胺 | capsule |
| Reblozyl | Luspatercept | injection |
| Reblozyl | Luspatercept | injection |
| Revlimid | 来那度胺 | capsule |
| Revlimid | 来那度胺 | capsule |
| Revlimid | 来那度胺 | capsule |
| Revlimid | 来那度胺 | capsule |
| Revlimid | 来那度胺 | capsule |
| Revlimid | 来那度胺 | capsule |
| Thalomid | 沙利度胺 | capsule |
| Thalomid | 沙利度胺 | capsule |
| Thalomid | 沙利度胺 | capsule |
| Thalomid | 沙利度胺 | capsule |
| VIDAZA | 阿扎胞苷 | injection |
| ZEPOSIA | Ozanimod | capsule |
| ZEPOSIA 7-Day Starter Pack | Ingredient not recorded (name-level) | kit |
| ZEPOSIA Starter Kit | Ingredient not recorded (name-level) | kit |